Meadow Creek Investment Management’s GSK GSK Stock Holding History

Meadow Creek Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,458	Closed	-$626K	–	1338
2018 Q3	$626K	Hold	12,458	–	–	0.01%	634
2018 Q2	$628K	Hold	12,458	–	–	0.01%	568
2018 Q1	$608K	Hold	12,458	–	–	0.01%	574
2017 Q4	$552K	Hold	12,458	–	–	0.01%	631
2017 Q3	$632K	Hold	12,458	–	–	0.01%	540
2017 Q2	$671K	Hold	12,458	–	–	0.02%	513
2017 Q1	$657K	Hold	12,458	–	–	0.02%	478
2016 Q4	$600K	Buy	+12,458	New	+$615K	0.02%	473

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Meadow Creek Investment Management's GSK Position: Q4 2018 in Review

Meadow Creek Investment Management sold out of GSK (GSK) in Q4 2018, closing a stake of 12,458 shares — an estimated $626K sold.

Meadow Creek Investment Management first reported a position in GSK in Q4 2016 and held it in 8 quarters. The position peaked at $671K in Q2 2017. 800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Meadow Creek Investment Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Meadow Creek Investment Management sold 12,458 GSK shares in Q4 2018, an estimated $626K.
Meadow Creek Investment Management first reported a position in GSK in Q4 2016 and held it in 8 quarters.
Meadow Creek Investment Management's GSK position peaked at $671K in Q2 2017.
800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Meadow Creek Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.